XWELL EPS - Earnings per Share 2012-2025 | XWEL
XWELL eps - earnings per share from 2012 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| XWELL Annual EPS | |
|---|---|
| 2024 | $-3.66 |
| 2023 | $-6.64 |
| 2022 | $-7.01 |
| 2021 | $0.60 |
| 2020 | $-41.00 |
| 2019 | $-259.80 |
| 2018 | $-1,536.15 |
| 2017 | $-1,552.96 |
| 2016 | $-1,896.19 |
| 2015 | $-1,308.13 |
| 2014 | $-14,833.48 |
| 2013 | $-7,560.76 |
| 2012 | $-7,320.73 |
| 2011 | $-3,960.40 |
| XWELL Quarterly EPS | |
|---|---|
| 2025-09-30 | $-0.26 |
| 2025-06-30 | $-0.56 |
| 2025-03-31 | $-1.00 |
| 2024-12-31 | $-1.59 |
| 2024-09-30 | $-0.99 |
| 2024-06-30 | $-0.48 |
| 2024-03-31 | $-0.60 |
| 2023-12-31 | $-1.19 |
| 2023-09-30 | $-2.76 |
| 2023-06-30 | $-1.37 |
| 2023-03-31 | $-1.32 |
| 2022-12-31 | $-3.09 |
| 2022-09-30 | $-1.52 |
| 2022-06-30 | $-1.60 |
| 2022-03-31 | $-0.80 |
| 2021-12-31 | $0.60 |
| 2021-09-30 | $1.00 |
| 2021-06-30 | $-0.80 |
| 2021-03-31 | $-0.20 |
| 2020-12-31 | $26.00 |
| 2020-09-30 | $-2.00 |
| 2020-06-30 | $-30.20 |
| 2020-03-31 | $-34.80 |
| 2019-12-31 | $63.20 |
| 2019-09-30 | $-33.60 |
| 2019-06-30 | $-193.00 |
| 2019-03-31 | $-96.40 |
| 2018-12-31 | $-163.82 |
| 2018-09-30 | $-135.01 |
| 2018-06-30 | $-157.22 |
| 2018-03-31 | $-1,080.11 |
| 2017-12-31 | $-472.85 |
| 2017-09-30 | $-240.02 |
| 2017-06-30 | $-432.04 |
| 2017-03-31 | $-408.04 |
| 2016-12-31 | $-288.03 |
| 2016-09-30 | $-408.04 |
| 2016-06-30 | $-864.09 |
| 2016-03-31 | $-336.03 |
| 2015-12-31 | $2,064.21 |
| 2015-09-30 | $-1,392.14 |
| 2015-06-30 | $-1,080.11 |
| 2015-03-31 | $-900.09 |
| 2014-12-31 | $-9,912.99 |
| 2014-09-30 | $-1,920.19 |
| 2014-06-30 | $-1,440.14 |
| 2014-03-31 | $-1,560.16 |
| 2013-12-31 | $-2,640.26 |
| 2013-09-30 | $-1,560.16 |
| 2013-06-30 | $-1,560.16 |
| 2013-03-31 | $-1,800.18 |
| 2012-12-31 | $1,560.16 |
| 2012-09-30 | $-2,160.22 |
| 2012-06-30 | $-1,560.16 |
| 2012-03-31 | $-5,160.52 |
| 2011-12-31 | $3,360.34 |
| 2011-09-30 | $-1,920.19 |
| 2011-06-30 | $-3,120.31 |
| 2011-03-31 | $-2,280.23 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.002B | $0.034B |
| XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $169.580B | 31.14 |
| HCA Healthcare (HCA) | United States | $106.416B | 17.62 |
| CVS Health (CVS) | United States | $104.957B | 12.07 |
| Elevance Health (ELV) | United States | $82.726B | 12.13 |
| Cencora (COR) | United States | $68.377B | 22.04 |
| Natera (NTRA) | United States | $33.600B | 0.00 |
| DiDi Global (DIDIY) | China | $23.532B | 21.74 |
| Labcorp Holdings (LH) | United States | $22.381B | 17.07 |
| Medpace Holdings (MEDP) | United States | $17.078B | 42.40 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.157B | 0.00 |
| Viatris (VTRS) | United States | $15.249B | 5.68 |
| ICON (ICLR) | Ireland | $15.081B | 14.96 |
| BioMerieux (BMXMF) | France | $14.360B | 0.00 |
| Solventum (SOLV) | United States | $13.921B | 13.51 |
| Revvity (RVTY) | United States | $13.350B | 24.58 |
| CochLear (CHEOY) | Australia | $12.343B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.026B | 21.24 |
| Avantor (AVTR) | United States | $8.345B | 12.75 |
| Sonic Healthcare (SKHHY) | Australia | $7.987B | 0.00 |
| HealthEquity (HQY) | United States | $7.383B | 27.61 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.209B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.142B | 42.58 |
| Bausch + Lomb (BLCO) | Canada | $6.089B | 39.98 |
| PACS (PACS) | United States | $5.503B | 33.47 |
| Sotera Health (SHC) | United States | $5.369B | 25.89 |
| Alignment Healthcare (ALHC) | United States | $4.724B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.945B | 51.72 |
| Concentras Parent (CON) | United States | $2.785B | 17.38 |
| Organon (OGN) | United States | $2.532B | 2.67 |
| Progyny (PGNY) | United States | $2.155B | 42.37 |
| Surgery Partners (SGRY) | United States | $2.044B | 26.33 |
| Establishment Labs Holdings (ESTA) | United States | $1.960B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.907B | 11.39 |
| Ardent Health (ARDT) | United States | $1.236B | 4.03 |
| Nutex Health (NUTX) | United States | $1.127B | 8.62 |
| Teladoc Health (TDOC) | United States | $1.127B | 0.00 |
| CareDx (CDNA) | United States | $1.081B | 17.66 |
| Omada Health (OMDA) | United States | $0.930B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.872B | 14.28 |
| InnovAge Holding (INNV) | United States | $0.806B | 0.00 |
| Embecta (EMBC) | United States | $0.715B | 4.07 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.685B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.596B | 0.00 |
| Enhabit (EHAB) | United States | $0.560B | 25.16 |
| CryoPort (CYRX) | United States | $0.547B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.489B | 0.00 |
| SBC Medicals (SBC) | United States | $0.459B | 8.43 |
| Auna S.A (AUNA) | Luxembourg | $0.419B | 6.74 |
| Agilon Health (AGL) | United States | $0.419B | 0.00 |
| Oncology Institute (TOI) | United States | $0.353B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.311B | 65.42 |
| Shoulder Innovations (SI) | United States | $0.310B | 0.00 |
| So-Young (SY) | China | $0.300B | 0.00 |
| Beauty Health (SKIN) | United States | $0.199B | 0.00 |
| KindlyMD (NAKA) | United States | $0.177B | 0.00 |
| LifeMD (LFMD) | United States | $0.174B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.133B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.131B | 0.00 |
| Biodesix (BDSX) | United States | $0.088B | 0.00 |
| DocGo (DCGO) | United States | $0.083B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.079B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.045B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.044B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 6.55 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.015B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |